负责公司各项外部合作及复星凯特在中国的首款CAR-T的商业化开发，包括销售、商务运营、市场、BD、和准入。

曾任上海复星医药集团战略部总监，参与包括复星凯特合资建立、复星领智在内的各项集团内重大投资合作项目。

2008至2015年期间于上海交通大学上海免疫学研究从事肿瘤免疫及自身免疫病研究。

He’s the Chief Commerical Officer of Fosun Kite Biotechnology Co., Ltd. In charge of Fosun Kite 's various external cooperation and the commercial development of the company's first CAR-T in China, including sales, commercial operations, marketing, access and BD.

He used to be the director of the strategy department of Fosun Pharma, and participated in various major investment cooperation projects within the group, including the establishment of Fosun Kite joint venture and Fosun Lead.

From 2008 to 2015, he was engaged in tumor immunity and autoimmune disease research at Shanghai Institute of Immunology, Shanghai Jiao Tong University.